Fulgent Genetics, Inc. ( FLGT) - Stock Earnings
FLGT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
FLGT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.4 million USD | 83.3 million USD |
| 2026Q1 | -24.8 million USD | 71.1 million USD |
| 2026Q2 | -29.5 million USD | 85.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
FLGT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -167.8 million USD | 289.2 million USD |
| 2024 | -42.7 million USD | 283.5 million USD |
| 2025 | -60.5 million USD | 322.7 million USD |
| 2026 Est. | — | — |
FLGT
Price: $20.10
52 week price:
Earnings Per Share: -2.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 235500
Ebitda: -1.0 millionMarket Capitalization: 584.5 million